Quintiles has formed a global alliance with Kadrige to enable biotech and pharma customers to reduce one of their largest fixed costs by transitioning from a traditional healthcare visit model to a 'hybrid' model that blends face-to-face physician discussions with live, remote e-detailing calls via the telephone and internet.
Subscribe to our email newsletter
The co-promotion agreement enables Quintiles and Kadrige to develop Web-Call centers, which allow medical sales representatives to train or call healthcare professionals on a full-time basis.
Kadrige and Quintiles said that their joint offering provides the full continuum of services and solutions required to evolve smoothly from an aging promotional model to a new one, based on the smart mix of multiple channels of communication that will bring to the biotech or pharma company, cost reductions, sales impact increase and a much larger flexibility to react to market evolutions.
Kadrige founder and chairman Olivier Cadou said that while many companies are piloting a hybrid approach, their agreement with Quintiles provides a real-world solution that saves customers time and money by delivering the right message at the right time to the right target through the right channel.
"This agreement expands our presence in the US and Europe through access to the largest biotech and pharma sales force in the world," Cadou said.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.